{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:01:10Z","timestamp":1790830870794,"version":"4.1.0"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>The parasympathetic nervous system is phylogenetically ancient. In humans, the vagus nerve is the brain\u2019s only pathway for bidirectional parasympathetic signaling with the thorax, abdomen, and upper pelvis. Unsurprisingly, the vagus nerve has played a significant role in scientific discovery and therapeutic applications, attracting the attention of Galen, Darwin, and Pavlov, among others. For example, Otto Loewi used the vagus nerve to gather data that confirmed Santiago Ram\u00f3n y Cajal\u2019s Neuron Doctrine. This intensive focus has led to a number of clinical advances related to vagus nerve function, including theories about mind\u2013body connections. Interestingly, reducing vagus nerve activity has been a successful strategy for some clinical conditions, such as peptic ulcer disease and obesity. In other conditions, increasing vagus nerve activity has been successful at improving patient outcomes, for example, in refractory seizures, drug-resistant depression, and stroke recovery; in each of these three conditions, the FDA has approved vagus nerve stimulation as a therapeutic intervention. Potential future developments in the therapeutic modulation of vagus nerve activity are discussed, including its role in perinatal brain development; manipulation of the vagus nerve as a portal for CNS access, as suggested in Parkinson\u2019s disease; and closed-loop systems that modulate vagus nerve activity in response to measurement of various forms of signaling, an approach that would be aided by the capacity to directly measure activity in individual vagus nerves.<\/jats:p>","DOI":"10.3389\/fneur.2026.1901477","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:51:37Z","timestamp":1790830297000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["What happens in vagus"],"prefix":"10.3389","volume":"17","author":[{"given":"Steven C.","family":"Cramer","sequence":"first","affiliation":[{"name":"Department of Neurology, University of California, Los Angeles and California Rehabilitation Institute","place":["Los Angeles, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.socscimed.2014.12.014","article-title":"A not so happy day after all: excess death rates on birthdays in the U.S","volume":"126","author":"Pena","year":"2015","journal-title":"Soc Sci Med"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1037\/10001-000","volume-title":"The Expression of the Emotions in Man and Animals","author":"Darwin","year":"1872"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1037\/0012-1649.36.1.54","article-title":"Child and mother cardiac vagal tone: continuity, stability, and concordance across the first 5 years","volume":"36","author":"Bornstein","year":"2000","journal-title":"Dev Psychol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1017\/S095457942000142X","article-title":"Prenatal maternal psychological distress and fetal developmental trajectories: associations with infant temperament","volume":"32","author":"Howland","year":"2020","journal-title":"Dev Psychopathol"},{"key":"ref5","volume-title":"Lectures on the Work of the Digestive Glands","author":"Pavlov","year":"1902"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","article-title":"Transneuronal propagation of pathologic alpha-synuclein from the gut to the brain models Parkinson's disease","volume":"103","author":"Kim","year":"2019","journal-title":"Neuron"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/v12010014","article-title":"Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system?","volume":"12","author":"Desforges","year":"2019","journal-title":"Viruses"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/nan.12298","article-title":"Review: sporadic Parkinson's disease: development and distribution of alpha-synuclein pathology","volume":"42","author":"Del Tredici","year":"2016","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/ana.24448","article-title":"Vagotomy and subsequent risk of Parkinson's disease","volume":"78","author":"Svensson","year":"2015","journal-title":"Ann Neurol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1111\/j.1528-1157.1990.tb05848.x","article-title":"Prevention of intractable partial seizures by intermittent vagal stimulation in humans: preliminary results","volume":"31","author":"Penry","year":"1990","journal-title":"Epilepsia"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"696543","DOI":"10.3389\/fmedt.2021.696543","article-title":"Evolution of the vagus nerve stimulation (Vns) therapy system technology for drug-resistant epilepsy","volume":"3","author":"Afra","year":"2021","journal-title":"Front Med Technol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1161\/STROKEAHA.117.019202","article-title":"Vagus nerve stimulation enhances stable plasticity and generalization of stroke recovery","volume":"49","author":"Meyers","year":"2018","journal-title":"Stroke"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1161\/strokeaha.115.010477","article-title":"Safety, feasibility, and efficacy of vagus nerve stimulation paired with upper-limb rehabilitation after ischemic stroke","volume":"47","author":"Dawson","year":"2016","journal-title":"Stroke"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1161\/strokeaha.118.022279","article-title":"Vagus nerve stimulation paired with upper limb rehabilitation after chronic stroke","volume":"49","author":"Kimberley","year":"2018","journal-title":"Stroke"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/S0140-6736(21)00475-X","article-title":"Vagus nerve stimulation paired with rehabilitation for upper limb motor function after ischaemic stroke (VNS-REHAB): a randomised, blinded, pivotal, device trial","volume":"397","author":"Dawson","year":"2021","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1161\/STROKEAHA.121.035648","article-title":"Vagus nerve stimulation for upper limb function: significant difference, but clinically important?","volume":"52","author":"Kwakkel","year":"2021","journal-title":"Stroke"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e218298","DOI":"10.1212\/WNL.0000000000218298","article-title":"Two-year retention of benefits after paired vagus nerve stimulation in stroke: follow-up of the Vns-rehab randomized clinical trial","volume":"107","author":"Kimberley","year":"2026","journal-title":"Neurology"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"100580","DOI":"10.1016\/j.arrct.2025.100580","article-title":"Vagus nerve stimulation paired with upper extremity rehabilitation for chronic stroke: real-world implementation and outcomes","volume":"8","author":"Saylor","year":"2026","journal-title":"Arch Rehabil Res Clin Transl"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/ana.27156","article-title":"Association that neuroimaging and clinical measures have with change in arm impairment in a phase 3 stroke recovery trial","volume":"97","author":"Schwarz","year":"2025","journal-title":"Ann Neurol"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1901477\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:51:44Z","timestamp":1790830304000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1901477\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":19,"alternative-id":["10.3389\/fneur.2026.1901477"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1901477","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"article-number":"1901477"}}